Media Release
Major Healthcare Improvements Announced: Expanded Access and Affordable Treatments for Endometriosis
9 February 2025
The Australian Government has announced a major healthcare package in response to community feedback and sustained advocacy efforts by the Australian Coalition for Endometriosis (ACE) and its member organizations.
From March 1, 2025, commonly used contraceptive pills like Yaz® and Yasmin® will be listed on the Pharmaceutical Benefits Scheme (PBS), reducing annual costs from $380 to just $126 or $30 with a concession card. This change will benefit around 50,000 people annually.
Additionally, bulk billing and increased Medicare rebates for IUDs and implants support more affordable health access options.
Jess Taylor, Chair of ACE, said:
“Our members told us they needed more access and affordable management options. We continue to advocate for our members policymakers, and this announcement is a direct result. These improvements provide a critical lifeline for people living with endometriosis.”
A key part of the package is the addition of 11 new Endometriosis and Pelvic Pain Clinics, expanding the network to 33 clinics nationwide.
“This is a significant win,” Jess Taylor said. “But our work doesn’t stop here—we’ll continue advocating for even more services and ongoing support.”
For media inquiries or further information, please contact:
Jess Taylor
Email: hello@acendo.com.au
Follow our journey on social media:
Facebook: @acendometriosis
Instagram: @acendometriosis
Twitter: @acendometriosis
#Endometriosis #PelvicPain #BetterHealthcare
About ACE:
ACE is the peak body for endometriosis and pelvic pain in Australia, advocating for improved healthcare, support services, and community awareness. Through collaboration and sustained advocacy, ACE works to improve outcomes for those affected by these conditions.
